Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage
Mark L. Vestal, Kimberly L. Hodulik, Jennifer Mando‐Vandrick, Michael L. James, Thomas L. Ortel, Matthew Fuller, Maria Notini, Mark Friedland, Ian J. Welsby
Topics & Concepts
MedicineRivaroxabanApixabanProthrombin complex concentrateAnesthesiaInternal medicineAtrial fibrillationWarfarinIntracerebral and Subarachnoid Hemorrhage ResearchAtrial Fibrillation Management and OutcomesNeurosurgical Procedures and Complications